Samyang Corporation
South Korea
Biologics Drug SubstanceGene Therapy
Compare Asian CDMOs across India, China, Japan, South Korea, and Southeast Asia. Filter by manufacturing type, regulatory approvals, and capacity for API synthesis, biologics, and drug products.
707 companies listed
Asia is the fastest-growing CDMO market, led by India (API synthesis powerhouse), China (increasingly sophisticated biologics and small molecule capabilities), South Korea (biosimilar manufacturing leader), and Japan (high-quality specialty manufacturing). Together, Asian CDMOs produce an estimated 60-80% of the world's active pharmaceutical ingredients.
India dominates small molecule API manufacturing. The country has over 3,000 pharmaceutical manufacturing facilities, many FDA-inspected, producing APIs for global generics markets. Indian CDMOs offer 30-50% cost advantages over Western alternatives for chemical synthesis. However, quality varies significantly -- due diligence on facility inspection history and quality systems is essential.
South Korea and Japan represent the premium end of Asian CDMO manufacturing. Samsung Biologics and Celltrion in South Korea have built world-class biologics facilities (up to 360,000L combined capacity). Japanese CDMOs (AGC Biologics' Chiba facility, FUJIFILM Diosynth) offer exceptional quality systems and specialized capabilities. China's WuXi Biologics and WuXi AppTec, though affected by BIOSECURE Act uncertainty, remain major global players.
Every country below has its own page with a ranked CDMO list, a country-zoomed facilities map, and the local regulatory picture. Counts are live manufacturing-site totals.
China
Newgen Biotech (Ningbo) is a Chinese marine biotechnology company established in 2013, focused on R&D, production, and sales of food nutritional supplements and marine-derived biological products. The company offers OEM/ODM services for probiotics, enzymes, and nutritional supplements, but its core business is food/nutraceutical products, not pharmaceutical drug manufacturing.
China
Paragon Medical is a global medical device contract design and manufacturing organization (CDMO) specializing in high-precision components and full medical devices. Products include orthopaedic implants, surgical instrumentation, cases and trays, drug delivery components, and single-use disposable devices. The company operates FDA-registered facilities with ISO 8 Class 100,000 cleanrooms. While Paragon Medical uses the term 'CDMO', it is a medical device manufacturer, NOT a pharmaceutical CDMO. It does not manufacture drugs, biologics, or drug products.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.
India
Patel Chem Specialities (also known as PCSPL) is an Indian specialty chemicals company based in Ahmedabad with manufacturing facilities in Vatva and Talod. The company focuses on economical excipients and API-related specialty chemicals for the pharmaceutical industry. It is a raw material and excipient supplier, not a contract drug manufacturer.
